Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation1

Abstract

The combination of alemtuzumab and Tac therapy without steroid use seems to efficiently prevent acute rejection in a significant number of patients without causing frequent opportunistic infections.